SIB LLC’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-45,477
Closed -$31K 22
2020
Q4
$31K Hold
45,477
0.02% 20
2020
Q3
$102K Hold
45,477
0.07% 20
2020
Q2
$163K Hold
45,477
0.12% 23
2020
Q1
$173K Hold
45,477
0.17% 22
2019
Q4
$137K Buy
+45,477
New +$118K 0.1% 23

Other funds holding BMY.RT

SIB LLC's BMY.RT Position: Q1 2021 in Review

SIB LLC sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 45,477 shares — an estimated $31K sold.

SIB LLC first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $173K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • SIB LLC reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • SIB LLC sold 45,477 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $31K.
  • SIB LLC first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • SIB LLC's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $173K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on SIB LLC's 13F filing for Q1 2021, filed 16 Apr 2021.